IP Library Granted Patent US 10,379,113
Granted Patent B2
US 10,379,113 · App. 15/413,008 · Granted Aug 13, 2019

Target detection

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,379,113
App. No.
15/413,008
Granted
Aug 13, 2019
Kind
B2
Abstract

The invention generally relates to methods for indicating whether an assay for isolating targets is properly isolating and detecting targets. Methods of the invention involve obtaining a sample suspected of a containing target, introducing a detectable marker into the sample, conducting an assay using magnet particles to isolate the detectable marker and the target if it is present in the sample, determining the presence or absence of the target; and confirming that the assay functioned properly by determining presence or absence of the detectable marker.

Claims (18)

1. A method for detecting a target and confirming proper functioning of an assay, the method comprising

obtaining a sample suspected of containing a target;

introducing a detectable marker into the sample;

incubating the sample to allow for coupling of the detectable marker and the target, if present, to magnetic particles comprising both a first binding moiety specific to the target and a second binding moiety specific to the detectable marker in the sample;

conducting an assay using magnetic particles to isolate the detectable marker and the target from the sample;

determining the presence or absence of the target in the sample; and

confirming proper function of the assay by determining presence or absence of the detectable marker.

2. The method of claim 1 , wherein the detectable marker comprises a microbe.

3. The method of claim 2 , wherein the microbe is detectable via a microbe-sensitive chromogen.

4. The method of claim 1 , wherein the detectable marker comprises a label.

5. The method of claim 4 , wherein the label is a fluorescent label.

6. The method of claim 1 , wherein the target is selected from the group consisting of cells, bacteria, viruses, fungi, and any combination thereof.

7. The method of claim 1 , wherein the assay comprises exposing the magnetic particles to a magnetic field.

8. The method of claim 7 , wherein the assay further comprises

flowing the sample through a channel comprising surface binding moieties specific to the targets and to the detectable marker attached to a surface of the channel; and binding the magnetic particles to the surface of the channel, wherein the step of applying a magnetic field brings the magnetic particles coupled to the target and detectable marker into proximity of the surface to facilitate binding of magnetic particles to the surface of the channel; and

washing away unbound magnetic particles and unbound sample components.

9. The method of claim 1 , wherein the method further comprises introducing the magnetic particles into the sample, wherein the magnetic particles are introduced prior to the conducting an assay step.

10. The method of claim 1 , wherein the presence of the target is determined separately from the presence of the detectable marker.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2017
From: NORVELL, MEGHAN E.
To: NANOMR, INC.
Reel/Frame 042479/0132 →
MERGER Recorded May 23, 2017
From: NANOMR, INC.
To: DNA ELECTRONICS, INC.
Reel/Frame 042479/0171 →
CHANGE OF NAME Recorded May 23, 2017
From: NANOMR, INC.
To: DNA ELECTRONICS, INC.
Reel/Frame 042537/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2017
From: DNA ELECTRONICS, INC.
To: DNAE GROUP HOLDINGS LIMITED
Reel/Frame 042537/0530 →